Cargando…

CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV

Detalles Bibliográficos
Autores principales: Unemori, P, Hunt, P, Leslie, K, Sinclair, E, Deeks, S, Martin, J, Maurer, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261828/
http://dx.doi.org/10.1186/1750-9378-4-S2-P43
_version_ 1782348338443583488
author Unemori, P
Hunt, P
Leslie, K
Sinclair, E
Deeks, S
Martin, J
Maurer, T
author_facet Unemori, P
Hunt, P
Leslie, K
Sinclair, E
Deeks, S
Martin, J
Maurer, T
author_sort Unemori, P
collection PubMed
description
format Online
Article
Text
id pubmed-4261828
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42618282014-12-10 CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV Unemori, P Hunt, P Leslie, K Sinclair, E Deeks, S Martin, J Maurer, T Infect Agent Cancer Poster Presentation BioMed Central 2009-06-17 /pmc/articles/PMC4261828/ http://dx.doi.org/10.1186/1750-9378-4-S2-P43 Text en Copyright © 2009 Unemori et al; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Unemori, P
Hunt, P
Leslie, K
Sinclair, E
Deeks, S
Martin, J
Maurer, T
CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
title CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
title_full CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
title_fullStr CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
title_full_unstemmed CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
title_short CD57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with Kaposi sarcoma and well-controlled HIV
title_sort cd57+, a global marker of immunosenescence, is elevated in an atypical cohort of patients with kaposi sarcoma and well-controlled hiv
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261828/
http://dx.doi.org/10.1186/1750-9378-4-S2-P43
work_keys_str_mv AT unemorip cd57aglobalmarkerofimmunosenescenceiselevatedinanatypicalcohortofpatientswithkaposisarcomaandwellcontrolledhiv
AT huntp cd57aglobalmarkerofimmunosenescenceiselevatedinanatypicalcohortofpatientswithkaposisarcomaandwellcontrolledhiv
AT lesliek cd57aglobalmarkerofimmunosenescenceiselevatedinanatypicalcohortofpatientswithkaposisarcomaandwellcontrolledhiv
AT sinclaire cd57aglobalmarkerofimmunosenescenceiselevatedinanatypicalcohortofpatientswithkaposisarcomaandwellcontrolledhiv
AT deekss cd57aglobalmarkerofimmunosenescenceiselevatedinanatypicalcohortofpatientswithkaposisarcomaandwellcontrolledhiv
AT martinj cd57aglobalmarkerofimmunosenescenceiselevatedinanatypicalcohortofpatientswithkaposisarcomaandwellcontrolledhiv
AT maurert cd57aglobalmarkerofimmunosenescenceiselevatedinanatypicalcohortofpatientswithkaposisarcomaandwellcontrolledhiv